[RCUS] QoQ Quarter Result on 31-Dec-2021 [#Q4]

Stock
[RCUS] Arcus Biosciences, Inc.
Announcement Date
23-Feb-2022
Financial Year
2021
Quarter
31-Dec-2021 [#Q4]
Profit Trend
QoQ- 458.28%
YoY- 638.77%
Quarter Report
RCUS's Result
RCUS's Financial Summary
View:
Show?
Quarter Result
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
Revenue 33,581 26,759 18,005 354,499 9,461 9,461 9,461 132.50%
PBT -64,919 -66,632 -66,989 281,183 -77,975 -75,970 -72,593 -7.17%
Tax -4,478 -2,350 1,004 1,815 -100 -100 438 -
NP -60,441 -64,282 -67,993 279,368 -77,975 -75,970 -72,593 -11.48%
Tax Rate - - - -0.65% - - - -
Total Cost 94,022 91,041 85,998 75,131 87,436 85,431 82,054 9.49%
Ratio Analysis
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
NP Margin -179.99 -240.23 -377.63 78.81 -824.17 -802.98 -767.29 -61.93%
Per Share
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
EPS -0.84 -0.90 -0.96 3.97 -1.11 -1.09 -1.08 -15.41%
EPS Diluted -0.84 -0.90 -0.96 3.71 -1.11 -1.09 -1.08 -15.41%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.